UPDATE : Thursday, August 13, 2020
Crystal Genomics to start P2 trial of Covid-19 treatment
Crystal Genomics said that the Ministry of Food and Drug Safety has given t...
by Lee Han-soo  |  2020-07-02 18:07
Boryung finds cancer drug has antiviral effect on Covid-19
Boryung Pharmaceutical said the company has found that Aplidin (ingredient:...
by Shim Hyun-tai  |  2020-07-02 18:07
Heliximith unveiled how HX109 inhibits prostate hyperplasia
Heliximith said that HX109, its prostate hyperplasia (BPH) prevention and t...
by Lee Han-soo  |  2020-07-02 15:03
MSD Korea reshuffles personnel before spinoff of Organon
MSD Korea has newly appointed key executives to lead each business unit bef...
by Kim Yun-mi  |  2020-07-02 13:44
Novartis’ asthma drug gets insurance benefit
Novartis’ allergic asthma and chronic urticarial drug Xolair (ingredient: o...
by Shim Hyun-tai  |  2020-07-01 20:05
Takeda Korea completes takeover of Shire Korea
Takeda Pharmaceuticals Korea announced Wednesday that it has completed the ...
by Lee Han-soo  |  2020-07-01 17:39
Hanmi to export dyslipidemia drug to Mexico via MSD
Hanmi Pharmaceutical said Wednesday that its partner, MSD, has obtained mar...
by Shim Hyun-tai  |  2020-07-01 14:19
Hanmi's short bowel syndrome treatment wins rare pediatric disease status
The U.S. Food and Drug Administration has granted a rare pediatric disease ...
by Lee Han-soo  |  2020-06-30 17:38
Hugel submits NDA for BTX product in Europe
Hugel said that it has submitted a new drug application (NDA) in Europe for...
by Lee Han-soo  |  2020-06-30 15:36
KPBMA to expand local drugmakers’ exchanges with Europe
The Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA) s...
by Kim Chan hyuk  |  2020-06-30 14:09
Bukwang to change clinical design for Covid-19 drug candidate
Bukwang Pharm said it would modify the clinical trial design on Levovir (cl...
by Kim Chan-hyuk  |  2020-06-30 13:18
Samsung Bioepis’ drug to join bevacizumab biosimilar competition in Europe
Samsung Bioepis’ Aybintio is expected to heat up biosimilars competition re...
by Kim Chan hyuk  |  2020-06-29 16:08
Vivozon to start P3b trial of nonnarcotic analgesics in US
Vivozon said that it has started recruiting patients for phase 3b clinical ...
by Lee Han-soo  |  2020-06-26 17:13
Helixmith pushes ahead with P3-2 trial for neuropathic pain treatment
Helixmith said that it has started its phase 3-2 trial for its gene therapy...
by Lee Han-soo  |  2020-06-26 16:38
Celltrion tops pharmaceutical brand reputation in June
Celltrion ranked the first in the local brand reputation of listed pharmace...
by Park Gi-taek  |  2020-06-26 15:23
10 more Korean drugmakers nestle in Boston to enter US market
Ten Korean pharmaceutical companies have additionally settled in the Cambri...
by Kim chan-hyuk  |  2020-06-26 14:12
Alteogen signs $3.8-billion tech transfer deal with a global pharma
Alteogen has signed a $3.87 billion tech transfer contract with a global ph...
by Shim Hyun-tai  |  2020-06-25 16:19
‘Use NEWS score system to detect high-risk Covid-19 patients early’
To reduce deaths caused by Covid-19 without treatment and vaccine, it is es...
by Song Soo-youn  |  2020-06-25 15:07
Hanmi, Novartis in patent dispute over diabetes drug
A court is to decide on the legal dispute between Hanmi Pharmaceutical and ...
by Kim Yun-mi  |  2020-06-25 13:59
Hanmi Science Presents 6 Great Visions for Post COVID-19
Hanmi Science with the gene of 'Innovation' presented six great vis...
by Lee Han-soo  |  2020-06-24 18:02
Back to Top